Search

everythinglearnresearchcommunity

for

Search:↓

Polyurethane dressings show promise for wound healing but need improvements to adapt better to the healing process.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Jarilla-Coffea extract gel effectively and safely increases eyelash and eyebrow thickness in women.

Non-drug therapies show promise for hair regrowth but need more research.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Excessive blue light harms eye cells and disrupts sleep patterns.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Infrared radiation can cause skin aging and cancer at high temperatures but may have therapeutic benefits at controlled levels.

Compound 4 is a promising treatment for hair loss with low toxicity.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

PXX is an effective and affordable photocatalyst for creating new chemical bonds in organic synthesis.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

The book has valuable information but is hard to read due to poor writing.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Gene variation affects prostate issues and hair loss.

Treatments for melanin disorders exist, but more effective options needed.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.